MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Does ‘DYT23’ exist? Report of a second family with adult- onset focal dystonia and a CACNA1AB mutation – causative or coincidental?

    P. Agarwal, M. Desai, S. Ravat (Mumbai, India)

    Objective: To describe clinical and genetic findings in a patient with focal adult-onset primary cranial dystonia and chorea, and a mutation in CACNA1B (also referred…
  • 2018 International Congress

    Frequency and Phenoptypic Spectrum of KMT2B Mutations in Childhood-Onset Dystonia: Results from a Single-Centre Cohort Study

    M. Carecchio, G. Zorzi, F. Invernizzi, C. Panteghini, L. Romito, F. Zibordi, V. Leuzzi, S. Galosi, P. Morana, B. Morana, C. Piano, A. Bentivoglio, C. Reale, F. Girotti, M. Topf, A. Joseph, M. Kurian, S. Lubbe, B. Garavaglia, N. Mencacci, N. Nardocci (Milan, Italy)

    Objective: To assess the frequency of KMT2B mutations in a cohort of patients with childhood-onset dystonia and characterize the related molecular and phenotypic spectrum. Background:…
  • 2018 International Congress

    Prevalence of REM Sleep Behavior Disorder in Sun City, Arizona

    D. Shprecher, A. Intorcia, M. Glass, J. Curry, J. Walker, B. Cutler, M. Callan, G. Serrano, N. Zhang, L. Sue, K. Davis, T. Beach (Sun City, AZ, USA)

    Objective: Determine prevalence of REM Sleep Behavior Disorder (RBD) in Sun City, Arizona Background: RBD is the strongest known clinical risk factor for neurodegenerative disorders…
  • 2018 International Congress

    Prevalence and characteristics of patients with progressive supranuclear palsy (PSP) in US health insurance claims data

    E. Viscidi, T. Dam, M. Juneja, L. Li, H. Krzywy, S. Eaton, S. Chen, S. Hall, A. Dilley (Cambridge, MA, USA)

    Objective: To estimate the prevalence of PSP in the United States (US) and present a profile of PSP patients. Background: Progressive supranuclear palsy (PSP) is…
  • 2018 International Congress

    Decision making in Huntington’s disease

    B. Heim, M. Peball, P. Ellmerer, C. Saft, S.M. von Hein, W. Poewe, K. Seppi, A. Djamshidian (Innsbruck, Austria)

    Objective: To investigate perceptual decision making and reflexion impulsivity in preclinical and manifest patients with Huntington’s disease (HD). Background: Huntington’s disease (HD) is an autosomal…
  • 2018 International Congress

    Driving performance of Huntington’s disease gene carriers

    M. Jacobs, E. Hart, Y. Mejia Miranda, G.J. Groeneveld, J. van Gerven, R. Roos (Leiden, Netherlands)

    Objective: To investigate if differences in driving performance between Huntington's disease (HD) gene carriers and healthy individuals can be detected with a driving simulator. Furthermore,…
  • 2018 International Congress

    Botulinum toxin A (BoNT A) treatment of postsurgical/posttraumatic focal movements not responding to oral therapy

    A. Lozza, A. Castagna, G. Castelnovo, E. Alfonsi, A. Montini, L. Marchetta, M. Fresia, A. Arrigo, R. Manni (Pavia, Italy)

    Objective: We report three cases of focal movement disorder following trauma or surgery. Oral therapies were ineffective in both patients and symptoms dramatically improved after…
  • 2018 International Congress

    Progressive encephalomyelitis with rigidity and myoclonus (PERM): Phenomenology, investigations and management of two recent cases

    T. Munteanu, Y. LLamas-Osorio, P. Cullinane, T. Lynch (Dublin, Ireland)

    Objective: To describe the diagnosis and treatment of two cases of anti-glycine receptor antibody positive PERM Background: PERM is a life-threatening autoimmune condition, which presents…
  • 2018 International Congress

    Diagnostic value and capability of DaT (dopamine-transporter) SEPCT scan to assess clinically uncertain Parkinsonism Diseases as a single institutional experience in Kuwait Population

    S. Al Tailji, M. Elgadafi1, W. Kamel, J. Al-Hashel (Kuwait, Kuwait)

    Objective: To evaluate the diagnostic value and capability of DaT scan to increase clinical confidence in order to confirm/rule out the diagnosis, change management and…
  • 2018 International Congress

    Eye movement disorders after cerebellar infaction

    M. Munteanu (Bucharest, Romania)

    Objective: This study aims to demostrate that the posterior cerebellar vermis controls both saccade precision and smooth pursuit velocity in humans. Background: The posterior vermis…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley